Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4271394 | The Journal of Sexual Medicine | 2010 | 9 Pages |
Abstract
There was an increase in lean mass during the study period in FtMs treated with testosterone undecanoate. Transsexual patients should be monitored for adverse effects on lipid profiles, blood pressure, and erythrocytosis during intramuscular testosterone undecanoate therapy. Mueller A, Haeberle L, Zollver H, Claassen T, Kronawitter D, Oppelt PG, Cupisti S, Beckmann MW, and Dittrich R. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Andreas MD, Lothar DSc, Hendryk MD, Tomma MD, Desiree MD, Patricia G. MD, Susanne MD, Matthias W. MD, Ralf DSc,